Davarpanah Nicole Negar — SEC Form 4 filings

SEC reporting owner CIK 2067554. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-07.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-05-12 to 2026-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cidara Therapeutics, Inc. (CDTX)Chief Medical Officer51 leg · 474 sh · $29,79711

Form 4 filings — Davarpanah Nicole Negar

FiledFormIssuerReported transactionsSource
2026-01-074Cidara Therapeutics, Inc. (CDTX)Disposition to issuer (D): 12,553 @ $221.50 · Disposition to issuer (D): 8,333 · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 62,597 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +1 moreEDGAR
2025-12-294Cidara Therapeutics, Inc. (CDTX)Gift (G): 450 @ $0EDGAR
2025-12-124Cidara Therapeutics, Inc. (CDTX)Tax withholding (F): 10,332 @ $219.60EDGAR
2025-09-154Cidara Therapeutics, Inc. (CDTX)Sale (S): 474 @ $62.86EDGAR
2025-05-124Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2067554 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →